ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 114

The Effect of Triage Assessments on Identifying Inflammatory Arthritis and Reducing Rheumatology Wait Times in Ontario

Claire Bombardier1, Sydney Brooks2, Mary Bell3, Angela Cesta4, Tetyana Kendzerskaya5, Raquel Sweezie6, Jessica Widdifield7, Laura Fullerton8, Vandana Ahluwalia9 and Arthur Karasik10, 1Toronto General Hospital Research Institute, Toronto, ON, Canada, 2The Arthritis Society, Toronto, ON, Canada, 3University of Toronto, Toronto, ON, Canada, 4Ontario Best Practices Research Initiative, University Health Network, Toronto, ON, Canada, 5Institute for Clinical Evaluative Studies, Toronto, ON, Canada, 6Arthritis Rehabilitation and Education Program, The Arthritis Society, Toronto, ON, Canada, 7McGill University, Montreal, QC, Canada, 8Division of Support, Systems and Outcomes, University Health Network, Toronto, ON, Canada, 9Ontario Rheumatology Association, Brampton, ON, Canada, 10Ontario Rheumatology Association, Toronto, ON, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Access to care, inflammatory arthritis, occupational therapy and physical therapy, Triage

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Health Services Research - ARHP Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  Excessive delays to rheumatologists have been documented and triage assessments of suspected IA referrals from primary care may be a key strategy to expedite access to rheumatologists. We evaluated the positive and negative predictive values (PPV and NPV) of triage assessments by extended role practitioners (ERP) for identifying patients with IA. We also estimated the time from primary care referral to rheumatology consultation, comparing those patients who were expedited by an ERP (suspected IA) versus those who were not.

Methods:  Patients with possible IA were identified from rheumatologists’ wait lists through a paper triage process. Patients were included if they were adults and newly referred by a general practitioner or nurse practitioner within the previous month. An ERP established a weekly triage clinic in each participating rheumatologist’s office and assessed each patient using a standardized tool to identify patients for an expedited rheumatologist consult. Non-expedited patients went back on the waiting list to receive the next available routine appointment. Patients were then followed for three months post referral with dates of rheumatologist consultations and clinical diagnoses identified by chart review. We determined the proportion of patients correctly triaged by ERPs for expedited access. The median (interquartile range) time from primary care referral to the first rheumatologist consultation was determined, comparing patients who were prioritized for an expedited assessment versus those who were not, and compared to the provincial average (median: 66 days)*.

Results:  Six rheumatologists agreed to participate in the study. Of 317 patients identified from the rheumatologists’ wait lists as having possible IA, 177(56%) met inclusion criteria and received an ERP triage assessment (female: 67%; mean age (SD): 53 (14)). Of these, 75/177 patients (42%) were prioritized by the therapist for an expedited appointment with the rheumatologist. For expedited patients, 71/75(95%) were seen by the rheumatologist within 3 months of referral and the median (IQR) time from referral to rheumatologist consultation was 37 (24.3-54.8) days. Upon consultation, the rheumatologist suspected IA or connective tissue disease (CTD) in 58/71(PPV=0.817). Among those not prioritized**, 68/101 patients (67%) were seen by the rheumatologist within three months of referral and the median (IQR) time from referral to rheumatologist visit was 100 (68.3-131.5) days. Of those, 13/68 received a differential diagnosis of IA/CTD (NPV=0.809).

Conclusion:   Triage by an ACPAC trained ERP resulted in a high number of patients with suspected IA/CTD being correctly prioritized for a rheumatology consultation. For prioritized patients, the wait time was less than the provincial median. These results suggest that an ERP working in a triage role can improve access to rheumatology care for patients with suspected IA.   *Widdifield et al. “Patterns of care among first-time referrals to rheumatologists: Characteristics and timeliness of consultations and treatment in Ontario, Canada” Arthritis Care & Research 2016; Apr 25. doi:10.1002/acr.22910. **1 patient missing


Disclosure: C. Bombardier, None; S. Brooks, None; M. Bell, None; A. Cesta, None; T. Kendzerskaya, None; R. Sweezie, None; J. Widdifield, None; L. Fullerton, None; V. Ahluwalia, None; A. Karasik, None.

To cite this abstract in AMA style:

Bombardier C, Brooks S, Bell M, Cesta A, Kendzerskaya T, Sweezie R, Widdifield J, Fullerton L, Ahluwalia V, Karasik A. The Effect of Triage Assessments on Identifying Inflammatory Arthritis and Reducing Rheumatology Wait Times in Ontario [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-effect-of-triage-assessments-on-identifying-inflammatory-arthritis-and-reducing-rheumatology-wait-times-in-ontario/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-triage-assessments-on-identifying-inflammatory-arthritis-and-reducing-rheumatology-wait-times-in-ontario/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology